Cystic Fibrosis Adherence Study

NCT04217889 | Completed

• 1 other identifier: 69HCL19_0410
• Study Type: observational
• Target: 197
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to assess the role of some factors which can influence the chest physiotherapy adherence in adult with cystic fibrosis. At first, we are going to try to consider the adherence of chest physiotherapy. Then, after dividing the patients into two groups - adherent or not adherent - we will attempt to identify the factors which can influence this adherence. It consists in a short questionnaire that the patient will fill during usual visits. The hypothesis is that the following factors can play a role in adherence of chest physiotherapy:

• Age
• Age of diagnostic
• Sex
• Fev1
• Number of antibiotic course
• Anxiety/depression
• Work time
• Socio-professional category
• Individual situation
• Physiotherapy with liberal physiotherapist and transport time
• Sport practice
• Family support
• Feeling of work time burden
• Feeling of physiotherapy efficiency
• Feeling of physiotherapy burden

Conditions

Cystic Fibrosis

Keywords

Cystic Fibrosis; Adherence to chest physiotherapy

Outcome Measures

Primary Outcomes (1)

• Quantity of chest physiotherapy

  If the quantity of chest physiotherapy alone (do well) or/and with physiotherapist is above or egal at 3 per week, the patient is "adherent" If the quantity of chest physiotherapy is under 3 sessions per week, the patient is "not- adherent" Then we measure the proportion of each group for each secondary factors.

  8 months

Study Arms (2)

Adherent patient

This group is composed of adherent patients to the chest physiotherapy based on the number of chest physiotherapy session per week.

Other: Questionnaire

Not-adherent patient

This group is composed of not-adherent patients to the chest physiotherapy based on the number of chest physiotherapy session per week.

Other: Questionnaire

Interventions

Questionnaire OTHER

Short questionnaire that can be completed during the usual consultation.

Adherent patient; Not-adherent patient

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Cohort of adult patients with cystic fibrosis and follow-up at the Lyon Reference Center.

You may qualify if:

• respiratory symptoms
• subnormal respiratory function (FEV1 \< 80%)
• without lung transplant

You may not qualify if:

• lung transplantation approach

Sponsors & Collaborators

• Hospices Civils de Lyon: lead

Study Sites (1)

Centre de Référence de la Mucoviscidose Lyon à l'hôpital Lyon Sud

Pierre-Bénite, France

Location

MeSH Terms

Conditions

Cystic Fibrosis

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Pancreatic Diseases; Digestive System Diseases; Lung Diseases; Respiratory Tract Diseases; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Infant, Newborn, Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 2, 2020
• First Posted: January 6, 2020
• Study Start: November 1, 2019
• Primary Completion: June 2, 2020
• Study Completion: June 2, 2020
• Last Updated: July 27, 2021

Record last verified: 2021-07

Locations

FR (1)